BMC Public Health invites submissions to our new Collection, Vaccine hesitancy. This Collection seeks to deepen our understanding of the complexities surrounding vaccine hesitancy, a phenomenon with significant implications for global public health.
Vaccinations have historically played a pivotal role in curbing the spread of infectious diseases, preventing millions of deaths globally. Vaccine hesitancy undermines the effectiveness of vaccination programs, leading to decreased herd immunity and an increased risk of preventable diseases. Advances in immunization have eradicated smallpox, significantly reduced the incidence of polio, and brought under control once-deadly diseases like measles, mumps, and rubella.
The COVID-19 pandemic also highlighted the urgency of widespread vaccination, showcasing global collaboration and innovation. However, the success of these achievements is threatened by vaccine hesitancy, which not only puts individuals at risk but also poses a broader public health challenge by eroding the collective defenses that vaccines afford to communities. Addressing vaccine hesitancy is paramount to sustaining and advancing the positive impact of vaccines on global health.
We invite contributions related to, but not limited to, the following themes:
- Determinants and drivers of vaccine hesitancy
- Communication strategies to address vaccine hesitancy
- Impact of vaccine hesitancy on vaccination coverage
- Trust in vaccines and healthcare systems
- Interventions and solutions to counter vaccine hesitancy
This collection supports and amplifies research related to SDG 3: “Good Health and Well-being” by promoting vaccination as a crucial preventive health measure. Additionally, addressing vaccine hesitancy supports SDG 10: “Reduced Inequality”, by ensuring equitable access to vaccines and reducing disparities in healthcare outcomes.
Image credit: Syda Productions / stock.adobe.com
